 |
 |

Endogenous Estradiol in Elderly Individuals
Cognitive and Noncognitive Associations
V. Senanarong, MD;
S. Vannasaeng, MD;
N. Poungvarin, MD;
S. Ploybutr, MSC;
S. Udompunthurak, MSC;
P. Jamjumras, RN;
L. Fairbanks, PhD;
J. L. Cummings, MD
Arch Neurol. 2002;59:385-389.
Objective To investigate an association between endogenous estradiol (E2) levels and cognition and behavior in elderly individuals.
Patients We studied 135 community-based men and women aged 52 to 85 years in
urban Bangkok, Thailand; 72 had dementia and 63 did not.
Materials and Methods Dementia was diagnosed using Diagnostic and Statistical
Manual of Mental Disorders, Fourth Edition, criteria after appropriate
investigations. Blood samples for assay were collected in the morning after
6 hours of fasting. Levels of E2 were measured by radioimmunoassay
(double antibody technique). The Thai version of the Mini-Mental State Examination
was used to assess cognition; the Neuropsychiatric Inventory was used to assess
neuropsychiatric symptoms; and the Functional Assessment Questionnaire was
used to assess instrumental activities of daily living.
Results There was no correlation between age and level of E2 in either
men or women. Individuals with lower estrogen levels had more behavioral disturbances
(men: r = -0.467, n = 45; P = .001; women: r = -0.384, n = 90; P<.001) and worse cognition (men: r = 0.316, n = 45; P = .03; women: r = 0.243, n = 90; P = .02) and function (men: r = -0.417, n = 45; P =
.004; women: r = -0.437, n = 90; P<.001). The threshold level of endogenous E2 in elderly
individuals for the risk of developing dementia was less than 15 pg/mL (<55
pmol/L) in men and less than 1 pg/mL (<4 pmol/L) in women.
Conclusion Lower E2 levels are correlated with poor cognitive, behavioral,
and functional status in older individuals.
From the Division of Neurology, Department of Medicine (Drs Senanarong
and Poungvarin and Ms Jamjumras), the Division of Endocrinology, Department
of Medicine (Dr Vannasaeng and Ms Ploybutr), and the Division of Clinical
Epidemiology, Department of Research Development (Mr Udompunthurak), Faculty
of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand; and
the Departments of Psychiatry and Biobehavioral Sciences (Drs Fairbanks and
Cummings) and Neurology (Dr Cummings), University of California, Los Angeles,
UCLA School of Medicine.
RELATED ARTICLE
Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 2002;59(3):492-494.
FULL TEXT
|